Sildenafil Citrate Market Share

  • Report ID: 2582
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Sildenafil Citrate Market Share

On the basis of regional analysis, the sildenafil citrate market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is predicted to hold largest revenue share by 2036, propelled by higher number of ED cases in the region. The market in Asia Pacific region is predicted to grow at the highest rate during the forecast period as a result of ageing population in countries such as India, China, Japan and increase in awareness towards erectile dysfunction and related disorders.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2582
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of sildenafil citrate is assessed at USD 1.65 billion.

Sildenafil Citrate Market size was valued at USD 1.58 billion in 2023 and is expected to reach USD 3.13 billion by 2036, expanding at around 5.4% CAGR during the forecast period i.e., between 2024-2036.

North America industry is predicted to hold largest revenue share by 2036, propelled by higher number of ED cases in the region.

The major players in the market are Pfizer Inc., Bayer AG, Apricus Biosciences, Inc., Cristália, Aglowmed Pharmaceuticals Ltd., Mylan N.V., VIVUS Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample